Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 10 of 10 publications.

Jeminiwa RN, Banjara B, Rahman MM, Garza KB, Chou CE, Franco-Watkins A, Fox B. What does it mean to live with asthma as a young adult? Poster presented at the 121st Virtual Annual Meeting of the American Association of Colleges of Pharmacy; July 13, 2020. [abstract] Am J Pharm Educ. 2020 Jun; 84(6):ajpe8221. doi: 10.5688/ajpe8221

Fernandez MM, Mordin M, Hadacek MB, Moecklinghoff C, Vloeberghs E, El khoury A, Tronczynski K. PrEP reimbursement and access in Europe: 2019 update. Poster presented at the 17th European AIDS Conference; November 2019. Basel, Switzerland. [abstract] HIV Med. 2019 Nov 6; 20(Suppl. 9):240. doi: 10.1111/hiv.12814

Brogan AJ, Talbird SE, Davis AE, Wild L, Flanagan D. Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK. HIV Med. 2019 Nov;20(10):668-80. doi: 10.1111/hiv.12788

Dong OM, Howard RM, Church R, Cottrell M, Forrest A, Innocenti F, Mosedale M, Kashuba A, Gonzalez D, Wiltshire T. Challenges and solutions for future pharmacy practice in the era of precision medicine. Am J Pharm Educ. 2018 Aug;82(6):6652. doi: 10.5688/ajpe6652

Schelfhout J, Jiang Y, Miles L, Merchant S, Graham J. Cost effectiveness of letermovir as cytomegalovirus prophylaxis in in allogeneic hematopoietic stem cell transplant recipients. Poster presented at the 2018 BMT Tandem Meetings; February 2018. Salt Lake City, UT. [abstract] Biol Blood Marrow Transplant. 2018 Mar; 24(3 Supplement):S384. doi: 10.1016/j.bbmt.2017.12.473

Wilkins E, Fisher M, Brogan AJ, Talbird SE, La EM. Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial. HIV Med. 2016 Aug;17(7):505-15. doi: 10.1111/hiv.12349

Reniers G, Armbruster B, Lucas A. Sexual networks, partnership mixing, and the female-to-male ratio of HIV infections in generalized epidemics: an agent-based simulation study. Demogr Res. 2015 Sep;33(15):425-50. doi: 10.4054/DemRes.2015.33.15

Brubaker L, Richter HE, Barber MD, Hsu Y, Rahn DD, Menefee S, Visco A, Spino C, Martin S, Meikle SF. Pelvic floor disorders clinical trials: participant recruitment and retention. Int Urogynecol J. 2013 Jan 1;24(1):73-9.

Mladsi D, Curtis S, Bell MJ, Ito T, Wilson M, Aboud M. Resource utilisation and cost of managing adverse events (AEs) associated with highly active antiretroviral therapy (HAART) in patients with HIV-1. Poster presented at the 18th Annual Conference of the British HIV Association; April 1, 2012. Birmingham, UK. [abstract] HIV Med. 2012 Apr 18; 13(SI):17-8.

Richter A, Pladevall M, Manjunath R, Lafata JE, Xi H, Simpkins J, Brar I, Markowitz N, Iloeje U, Irish W. Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV-infected patients: a retrospective cohort study. HIV Med. 2005 Mar 1;6(2):79-90.